| Heading: |
NHS: Drugs |
| Question ID: |
1791258 |
| UIN: |
43292 |
| House: |
Commons |
| Date tabled: |
2025-04-01 |
| Asking Member ID: |
5255 |
| Asking Member display name: |
Joe Robertson
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Joe Robertson
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the Innovative Medicines Fund in providing access to non-cancer medicines. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Innovative Medicines Fund was launched in June 2022, building on the successful Cancer Drugs Fund and supporting patient access to the most promising new medicines while further evidence is collected on their use to address clinical uncertainty.Since ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |